These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37551295)

  • 1. Nonparametric inference of complier quantile treatment effects in randomized trials with imperfect compliance.
    Mao L
    Biostat Epidemiol; 2022; 6(2):249-265. PubMed ID: 37551295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of causal quantile effects with a binary instrumental variable and censored data.
    Wei B; Peng L; Zhang MJ; Fine JP
    J R Stat Soc Series B Stat Methodol; 2021 Jul; 83(3):559-578. PubMed ID: 35444487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.
    Yu W; Chen K; Sobel ME; Ying Z
    J R Stat Soc Series B Stat Methodol; 2015 Mar; 77(2):397-415. PubMed ID: 25870521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling compliers and noncompliers for instrumental variable analysis with covariates: A weighting approach.
    Choi BY
    PLoS One; 2023; 18(6):e0283223. PubMed ID: 37319247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
    Antonelli J; Han B; Cefalu M
    Stat Med; 2017 Dec; 36(29):4604-4615. PubMed ID: 28833307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumental variable estimation of truncated local average treatment effects.
    Choi BY
    PLoS One; 2021; 16(4):e0249642. PubMed ID: 33819276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complier stochastic direct effects: identification and robust estimation.
    Rudolph KE; Sofrygin O; van der Laan MJ
    J Am Stat Assoc; 2021; 116(535):1254-1264. PubMed ID: 34531623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kernel nonparametric quantile estimator for right-censored competing risks data.
    Fan C; Ding G; Zhang F
    J Appl Stat; 2020; 47(1):61-75. PubMed ID: 35707603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting Instrumental Variable methods for causal inference to the Estimand Framework.
    Bowden J; Bornkamp B; Glimm E; Bretz F
    Stat Med; 2021 Nov; 40(25):5605-5627. PubMed ID: 34288021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects.
    Nguyen TQ; Stuart EA; Scharfstein DO; Ogburn EL
    Stat Med; 2024 Aug; 43(19):3664-3688. PubMed ID: 38890728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handling Missing Data in Instrumental Variable Methods for Causal Inference.
    Kennedy EH; Mauro JA; Daniels MJ; Burns N; Small DS
    Annu Rev Stat Appl; 2019 Mar; 6(1):125-148. PubMed ID: 33834080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric estimation of the causal effect of a stochastic threshold-based intervention.
    van der Laan L; Zhang W; Gilbert PB
    Biometrics; 2023 Jun; 79(2):1014-1028. PubMed ID: 35526218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.